KRX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 08/07/2026 15:30
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization106,383 mln
Float2.16 mln
Earnings Date08/18/2025
EPS
876
Exceptional
P / E
8.56
Undervalued
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.76
Likely reliable
Relative Strength
88
/ 100
Strongly outperforming
Debt / Equity
0.53
Moderate leverage
Business Description
Founded in 1959 and based in Seoul, Jeil Pharma Holdings is a South Korean pharmaceutical company that produces active drug ingredients, improved formulations, and generic medicines across a wide range of therapeutic areas, including heart health, cancer, infectious diseases, and neurology. The company sells both raw pharmaceutical ingredients and finished medicines, distributing its products to customers in roughly 40 countries across Southeast Asia, Africa, and Latin America.
